ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Nilutamide Tablet shortage

To Be Discontinued  2 presentations · 1 manufacturers · first FDA posting 2025-12-01 · last update 2025-12-01

Manufacturers: Advanz Pharma (US) Corp.

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Nilandron, Tablet, 150 mg (NDC 59212-111-14)Advanz Pharma (US) Corp.To Be Discontinued
 —Product to expire in March 2026; Discontinuation of the manufacture of the drugPosted 12/01/2025
Updated 12/01/2025
Discontinued 12/01/2025
Nilandron, Tablet, 150 mg (NDC 66993-212-38)Advanz Pharma (US) Corp.To Be Discontinued
 —Product to expire in March 2026; Discontinuation of the manufacture of the drugPosted 12/01/2025
Updated 12/01/2025
Discontinued 12/01/2025

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)